Points of Pride

Latest News

Third Rock Ventures launches Fulcrum Therapeutics

Michael Green of UMMS a co-founder Mission to unlock gene control mechanisms, develop small molecule therapies for disease. 


SPINRAZA™ (nusinersen)  

Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy.


FDA Approves Merck's ZINPLAVA

Reduce Recurrence of Clostridium difficile Infection in Adult Patients Receiving Antibacterial Drug Treatment.




Office of Technology Management Statistics  

Average per year for the past 10 years. 




Licensing Revenue

Out of 155 U.S. 

Universities in licensing revenue


in NIH funds 

Among New England Medical Schools 





Invention Disclosures

Patent Applications


Patents Issued 







Deals Done 

▴ Back To Top
Section Menu To Top